---
layout: default
title: Oxytetracycline
description: "Oxytetracycline çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 121
evidence_level: L5
indication_count: 10
---

# Oxytetracycline

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Oxytetracycline è—¥å¸«ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Oxytetracycline å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Oxytetracycline ç‚ºå»£æ•ˆæ€§å››ç’°ç´ é¡æŠ—ç”Ÿç´ ï¼ŒTxGNN é æ¸¬å…¶å¯èƒ½å°å¤–è€³ç‚æœ‰æ²»ç™‚æ•ˆæœï¼Œæ–‡ç»é¡¯ç¤ºå¤šé …ç ”ç©¶å·²é©—è­‰å…¶åœ¨è€³éƒ¨æ„ŸæŸ“çš„ç™‚æ•ˆï¼Œè­‰æ“šç­‰ç´šä¸­ç­‰ã€‚
</p>

---

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥å“åç¨± | Oxytetracycline (ç¾¥å››ç’°ç´ ) |
| DrugBank ID | DB00595 |
| å°ç£å•†å“å | é¹½é…¸ç¾¥å››ç’°ç´ è† å›Šç­‰ |
| åŸé©æ‡‰ç—‡ | é©è˜­æ°é™½æ€§åŠé™°æ€§èŒæ„ŸæŸ“ç—‡ã€èºæ—‹èŒæ„ŸæŸ“ç—‡ã€ç«‹å…‹æ¬¡é«”æ„ŸæŸ“ç—‡ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | conjunctivitisã€chronic rhinosinusitisã€chronic ethmoidal sinusitisã€sinusitisã€paranasal sinus neoplasm (disease)ã€punctate epithelial keratoconjunctivitisã€postinfectious vasculitisã€post-bacterial disorderã€post-infectious syndromeã€infective urethral stricture |
| è­‰æ“šç­‰ç´š | L2 (å–®ä¸€ RCT / å¤šå€‹è‡¨åºŠç ”ç©¶) |
| TxGNN é æ¸¬åˆ†æ•¸ | é«˜åˆ†é æ¸¬ |

---

## ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†

### æ©Ÿè½‰é€£çµ

1. **å»£æ•ˆæŠ—èŒä½œç”¨**ï¼šOxytetracycline æŠ‘åˆ¶ç´°èŒ 30S æ ¸ç³–é«”äºåŸºï¼Œå°é€ æˆå¤–è€³ç‚çš„å¸¸è¦‹ç—…åŸé«”å¦‚è‘¡è„çƒèŒã€ç¶ è†¿æ¡¿èŒç­‰æœ‰æ•ˆã€‚

2. **å±€éƒ¨è£½åŠ‘å¯ç”¨æ€§**ï¼šå·²æœ‰å« oxytetracycline çš„è€³ç”¨è¤‡æ–¹è£½åŠ‘ä¸Šå¸‚ï¼Œå¸¸èˆ‡ polymyxin B æˆ–é¡å›ºé†‡åˆç”¨ã€‚

3. **å”åŒæŠ—èŒä½œç”¨**ï¼šç ”ç©¶é¡¯ç¤º EDTA-Tris èˆ‡ oxytetracycline åˆç”¨å°ç¶ è†¿æ¡¿èŒæœ‰å”åŒæŠ‘åˆ¶ä½œç”¨ã€‚

---

## è‡¨åºŠè©¦é©—è­‰æ“š

| è©¦é©—é¡å‹ | ç ”ç©¶å…§å®¹ | çµæœæ‘˜è¦ |
|----------|----------|----------|
| éš¨æ©Ÿå°ç…§è©¦é©— | æ¯”è¼ƒ Auricularum è€³ç²‰ (å« oxytetracycline) èˆ‡ ciprofloxacin åŠ tobramycin æ»´è€³åŠ‘ | ä¸‰çµ„æ²»ç™‚æ€¥æ€§å¤–è€³ç‚å‡æœ‰æ•ˆ |

---

## æ–‡ç»è­‰æ“š

### å¤–è€³ç‚ç›¸é—œç ”ç©¶

| PMID | ç™¼è¡¨å¹´ä»½ | ç ”ç©¶é¡å‹ | ä¸»è¦ç™¼ç¾ |
|------|----------|----------|----------|
| 12019482 | 2002 | éš¨æ©Ÿå°ç…§è©¦é©— | å« oxytetracycline çš„è€³ç²‰åœ¨æ²»ç™‚æ€¥æ€§å¤–è€³ç‚èˆ‡ ciprofloxacinã€tobramycin æ»´åŠ‘ç™‚æ•ˆç›¸ç•¶ |
| 15823803 | 2005 | å‹•ç‰©å¯¦é©— | Hydrocortisone-oxytetracycline-polymyxin B è¤‡æ–¹å°å¤–è€³é“çœŸèŒåŠç´°èŒæ„ŸæŸ“æœ‰æ•ˆ |
| 11583468 | 2001 | å‹•ç‰©å¯¦é©— | å¤–è€³ç‚å‹•ç‰©æ¨¡å‹é¡¯ç¤ºé¡å›ºé†‡åˆä½µæŠ—ç”Ÿç´ æ²»ç™‚æœ‰æ•ˆ |
| 6412426 | 1983 | é«”å¤–ç ”ç©¶ | EDTA-Tris èˆ‡ oxytetracycline å°ç¶ è†¿æ¡¿èŒæœ‰å”åŒå¢æ•ˆä½œç”¨ |
| 6414345 | 1983 | é«”å¤–ç ”ç©¶ | Oxytetracycline èˆ‡ EDTA-tromethamine åˆç”¨å°ç¶ è†¿æ¡¿èŒæœ‰å”åŒæŠ‘åˆ¶ä½œç”¨ |

---

## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰å­—è™Ÿ | å•†å“å | åŠ‘å‹ | é©æ‡‰ç—‡ | ç‹€æ…‹ |
|-----------|--------|------|--------|------|
| å…§è¡›è—¥è£½å­—ç¬¬006780è™Ÿ | é¹½é…¸ç¾¥å››ç’°ç´ è† å›Š 250mg | è† å›Š | æ”¯æ°£ç®¡ç‚ã€Qç†±ã€ç´°èŒæ€§ç—¢ç–¾ã€æ‰æ¡ƒè…ºç‚ã€è»Ÿæ€§ä¸‹ç–³ã€è€³ç‚ã€èƒƒè…¸ç‚ | æœ‰æ•ˆ |

**æ³¨æ„**ï¼šåŸé©æ‡‰ç—‡å·²åŒ…å«ã€Œè€³ç‚ã€ï¼Œæ­¤é æ¸¬å¯¦éš›ä¸Šç‚ºé©æ‡‰ç—‡ç¯„åœå…§çš„æ‡‰ç”¨ã€‚

å¤§å¤šæ•¸å« oxytetracycline çš„å°ç£è—¥è­‰å·²è¨»éŠ·ï¼Œç›®å‰æœ‰æ•ˆè—¥è­‰æœ‰é™ã€‚

---

## å®‰å…¨æ€§è€ƒé‡

### é‡è¦è­¦èª

- **å…‰æ•æ„Ÿæ€§**ï¼šå››ç’°ç´ é¡å¯èƒ½å°è‡´åš´é‡å…‰æ•æ„Ÿåæ‡‰
- **ç‰™é½’åŠéª¨éª¼ç™¼è‚²å½±éŸ¿**ï¼šå­•å©¦åŠ8æ­²ä»¥ä¸‹å…’ç«¥ç¦ç”¨ï¼Œå¯èƒ½é€ æˆç‰™é½’æ°¸ä¹…è®Šè‰²åŠéª¨éª¼ç™¼è‚²éšœç¤™
- **è…¸èƒƒé“åæ‡‰**ï¼šå¸¸è¦‹å™å¿ƒã€å˜”åã€è…¹ç€‰

### è—¥ç‰©äº¤äº’ä½œç”¨

| äº¤äº’ä½œç”¨è—¥ç‰© | å½±éŸ¿èªªæ˜ |
|-------------|----------|
| åˆ¶é…¸åŠ‘ (å«é‹ã€é‚ã€éˆ£) | é™ä½ oxytetracycline å¸æ”¶ |
| å£æœæŠ—å‡è¡€åŠ‘ | å¯èƒ½å¢å¼·æŠ—å‡ä½œç”¨ |
| é’é»´ç´ é¡ | å¯èƒ½é™ä½é’é»´ç´ ç™‚æ•ˆ |
| å£æœé¿å­•è—¥ | å¯èƒ½é™ä½é¿å­•æ•ˆæœ |

### ç‰¹æ®Šæ—ç¾¤

- **å­•å©¦**ï¼šç¦å¿Œä½¿ç”¨ (Category D)
- **å“ºä¹³å©¦å¥³**ï¼šä¸å»ºè­°ä½¿ç”¨
- **8æ­²ä»¥ä¸‹å…’ç«¥**ï¼šç¦å¿Œä½¿ç”¨
- **è…åŠŸèƒ½ä¸å…¨**ï¼šéœ€èª¿æ•´åŠ‘é‡

---

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**ä¹³è£½å“ (dairy products)** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šAdministration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.
- å»ºè­°ï¼šTetracycline should be administered one hour before or two hours after meals.


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Diseases requiring hemodialysis** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šOxytetracycline is partially removed by hemodialysis...

**è‚è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- æ‡‰é¿å…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚é¢¨éšªåŒ…æ‹¬ï¼šè‚æ¯’æ€§ã€‚

**è…è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚

**Esophageal Diseases** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šThe use of oral tetracycline capsules and tablets has been associated with esophageal irritation and ulceration in patients who ingested the drug with...

**Colitis** ğŸŸ¢ Minor
- é¢¨éšªåŒ…æ‹¬ï¼šæ„ŸæŸ“ã€‚å¯èƒ½æœ‰è‡´å‘½é¢¨éšªã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### æ•´é«”è©•ä¼°

Oxytetracycline ç”¨æ–¼å¤–è€³ç‚çš„é æ¸¬å…·æœ‰è‰¯å¥½çš„è­‰æ“šæ”¯æŒï¼š

1. **è­‰æ“šç­‰ç´šä¸­ç­‰ (L2)**ï¼šæœ‰éš¨æ©Ÿå°ç…§è©¦é©—æ”¯æŒå…¶ç™‚æ•ˆ
2. **æ©Ÿè½‰åˆç†**ï¼šå»£æ•ˆæŠ—èŒä½œç”¨å¯æ¶µè“‹å¤–è€³ç‚å¸¸è¦‹ç—…åŸ
3. **å·²æœ‰ä¸Šå¸‚è£½åŠ‘**ï¼šå« oxytetracycline çš„è¤‡æ–¹è€³ç”¨è£½åŠ‘å·²åœ¨åœ‹éš›ä¸Šä½¿ç”¨
4. **å°ç£ç¾æ³**ï¼šåŸé©æ‡‰ç—‡å·²åŒ…å«è€³ç‚ï¼Œä½†å¤§éƒ¨åˆ†è—¥è­‰å·²è¨»éŠ·

### å»ºè­°è¡Œå‹•

- **è€ƒæ…®å¾©æ´»è—¥è­‰**ï¼šè‹¥æœ‰è‡¨åºŠéœ€æ±‚ï¼Œå¯è€ƒæ…®é‡æ–°ç”³è«‹å« oxytetracycline çš„è€³ç”¨è£½åŠ‘
- **è©•ä¼°æ›¿ä»£é¸é …**ï¼šç›®å‰ ciprofloxacin åŠ ofloxacin è€³æ»´åŠ‘ç‚ºä¸»æµæ²»ç™‚
- **å±€éƒ¨è£½åŠ‘å„ªå…ˆ**ï¼šé™ä½å…¨èº«æ€§å‰¯ä½œç”¨é¢¨éšª

### è‡¨åºŠå»ºè­°

å°æ–¼å¤–è€³ç‚æ²»ç™‚ï¼Œoxytetracycline å¯ä½œç‚ºæ›¿ä»£é¸é …ï¼Œç‰¹åˆ¥æ˜¯ï¼š
- å° fluoroquinolone éæ•çš„æ‚£è€…
- éœ€è¦åˆä½µæŠ—çœŸèŒæ²»ç™‚çš„æ··åˆæ„ŸæŸ“

---

*æœ¬å ±å‘Šç”± TxGNN é æ¸¬ç³»çµ±ç”Ÿæˆï¼Œåƒ…ä¾›ç ”ç©¶åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Amorolfine]({{ "/drugs/amorolfine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Trihexyphenidyl]({{ "/drugs/trihexyphenidyl/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Scopolamine]({{ "/drugs/scopolamine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Threonine]({{ "/drugs/threonine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Iodixanol]({{ "/drugs/iodixanol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Oxytetracyclineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/oxytetracycline/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_oxytetracycline,
  title = {Oxytetracyclineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/oxytetracycline/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
